Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice
Public ClinicalTrials.gov record NCT01134315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules as Determined by Hypercalcemia in Pediatric Patients Ages 0 to 16 With Chronic Kidney Disease (CKD) Stage 5 Receiving Peritoneal Dialysis (PD) Within Current Clinical Practice
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study was to observe the safety of paricalcitol utilization in pediatric participants (ages 0 to 16 years old) being treated for secondary hyperparathyroidism (SHPT). Participants were to be followed for a minimum of 3 months and up to approximately 36 months to monitor the incidence of hypercalcemia (high calcium levels in blood).
Study identification
- NCT ID
- NCT01134315
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 61 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- Up to 16 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2010 (Type not available)
- Primary completion
- May 2012 (Actual)
- Completion
- May 2012 (Actual)
- Last update posted
- Aug 13, 2013
2010 – 2012
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 37082 | Birmingham | Alabama | 35255 | — |
| Site Reference ID/Investigator# 26762 | Gainesville | Florida | 32610 | — |
| Site Reference ID/Investigator# 28529 | Orlando | Florida | 32801 | — |
| Site Reference ID/Investigator# 26748 | Atlanta | Georgia | 30322 | — |
| Site Reference ID/Investigator# 37582 | New Orleans | Louisiana | 70118 | — |
| Site Reference ID/Investigator# 39973 | Baltimore | Maryland | 21287 | — |
| Site Reference ID/Investigator# 26769 | Boston | Massachusetts | 02115 | — |
| Site Reference ID/Investigator# 26768 | Detroit | Michigan | 48201 | — |
| Site Reference ID/Investigator# 26747 | Kansas City | Missouri | 64108 | — |
| Site Reference ID/Investigator# 26749 | Akron | Ohio | 44308 | — |
| Site Reference ID/Investigator# 26751 | Cincinnati | Ohio | 45229 | — |
| Site Reference ID/Investigator# 26765 | Columbus | Ohio | 43205 | — |
| Site Reference ID/Investigator# 28528 | Oklahoma City | Oklahoma | 73104 | — |
| Site Reference ID/Investigator# 26763 | Portland | Oregon | 97227 | — |
| Site Reference ID/Investigator# 28526 | Charlottesville | Virginia | 22908 | — |
| Site Reference ID/Investigator# 26758 | Seattle | Washington | 98105 | — |
| Site Reference ID/Investigator# 40382 | Madison | Wisconsin | 53792 | — |
| Site Reference ID/Investigator# 26759 | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01134315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2013 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01134315 live on ClinicalTrials.gov.